Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis
Conditions: Rhematoid Arthritis Interventions: Drug: Prednisolone; Drug: Placebo Sponsors: Chinese University of Hong Kong Not yet recruiting
ClinicalTrials.gov
ClinicalTrials.gov
Category Added in a WPeMatico Campaign
ClinicalTrials.gov
Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Conditions: Immune-Related Adverse Events; Lupus Erythematosus, Systemic; Sjogren Syndrome; Systemic Sclerosis (SSc); Inflammatory Myopathies; Solid Tumors Interventions: Drug: Immune Checkpoint
ClinicalTrials.gov
“Validity and Reliability of Pelvic Floor Distress Inventory-20 in Primary Sjögren’s Syndrome”
Conditions: Sjogren Syndrome Interventions: Other: the validity and reliability study Sponsors: Pamukkale University Completed
ClinicalTrials.gov
Temporomandibular Joint Dysfunction in Sjögren’s Syndrome
Conditions: Sjogren Syndrome Interventions: Diagnostic Test: Temporomandibular Joint Function Sponsors: Pamukkale University Completed
ClinicalTrials.gov
Rehabilitation Exercise Intervention for Rheumatoid Arthritis Patients Using Artificial Intelligence-Based Exercise Prescription System
Conditions: Rheumatoid Arthritis (RA) Interventions: Other: AI Exercise Prescription; Other: education and basic joint mobility exercises; Other: paper-based exercise prescription
ClinicalTrials.gov
Managed Access Programs for VAY736, Ianalumab
Conditions: Primary Immune Thrombocytopenia; Sjögren’s Syndrome Interventions: Drug: ianalumab Sponsors: Novartis Pharmaceuticals Temporarily not available
ClinicalTrials.gov
Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares: A Pragmatic Randomized Clinical Trial
Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: Glucocorticoid (GC) Sponsors: Sunnybrook Health Sciences Centre; The Physicians’ Services Incorporated Foundation Not yet
ClinicalTrials.gov
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: F8IL10 Sponsors: Philogen S.p.A. Not yet recruiting
ClinicalTrials.gov
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Conditions: Autoimmune Diseases; Systemic Lupus Erythematosus; Systemic Sclerosis; Primary Sjögren Syndrome; Rheumatoid Arthritis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Interventions: Biological: anti-CD19/BCMA
ClinicalTrials.gov
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Conditions: SLE (Systemic Lupus); RA – Rheumatoid Arthritis Interventions: Drug: NTR1011 Sponsors: Neutrolis Recruiting
ClinicalTrials.gov
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus; Lupus Nephritis (LN); Sjogren’s Syndrome; Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome Interventions: Drug: YTS109
ClinicalTrials.gov
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus (SLE); Systemic Sclerosis; Sjogren’s Syndrome (SS); Inflammatory Myopathy; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiphospholipid Syndrome Interventions: Drug:
ClinicalTrials.gov
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
Conditions: Moderate to Severe Active Rheumatoid Arthritis Interventions: Drug: SHR-3045 Injection; Drug: SHR-3045 Injection Placebo Sponsors: Guangdong Hengrui Pharmaceutical Co.,
ClinicalTrials.gov
A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA).
Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: KT501 Sponsors: Kali Therapeutics, Inc. Not yet recruiting
ClinicalTrials.gov
A Phase 1b Open-label Study to Evaluate Safety in Participants With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Biological: XmAb13676 Sponsors: Xencor, Inc. Recruiting
ClinicalTrials.gov
Comparison of Glucocorticoid Tapering Schedules in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: Prednisolone; Drug: Prednisolone; Drug: Prednisolone Sponsors: Seoul National University Hospital; Seoul National University Bundang
ClinicalTrials.gov
Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
Conditions: Rheumatoid Arthritis (RA Interventions: Behavioral: Peer Coach; Behavioral: Healthy Horizons Sponsors: Weill Medical College of Cornell University; Bristol-Myers Squibb
ClinicalTrials.gov
Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting
Conditions: Systemic Lupus Erythematosus; Rheumatoid Arthritis; Multiple Sclerosis; Autoimmune Diseases; Chronic Inflammatory Syndromes; Immune Dysregulation Interventions: Device: Low-Frequency Electromagnetic Resonance
ClinicalTrials.gov
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Conditions: Autoimmune Diseases; Rheumatoid Arthritis (RA); Inflammatory Bowel Disease (IBD); Psoriasis (PsO) Interventions: Other: Offered an academic detailing session; Other:
ClinicalTrials.gov
Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)
Conditions: Interstitial Lung Disease Due to Systemic Disease (Disorder); Interstitial Lung Disease in Patients With Rheumatoid Arthritis; Interstitial Lung Disease
ClinicalTrials.gov
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Conditions: Refractory Autoimmune Diseases Interventions: Genetic: BMS-986515; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Tocilizumab Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb
ClinicalTrials.gov
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Conditions: Rheumatoid Arthritis Interventions: Drug: Afimkibart; Drug: Placebo Sponsors: Hoffmann-La Roche Not yet recruiting
ClinicalTrials.gov
A Study of SPY072 in Rheumatic Disease
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Rheumatic Diseases; Rheumatic Joint Disease; PsA (Psoriatic Arthritis); AxSpA; Rheumatologic Disease Interventions: Drug:
ClinicalTrials.gov
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
Conditions: Arthritis, Rheumatoid Interventions: Drug: Tulisokibart; Drug: Placebo; Drug: Methotrexate Sponsors: Merck Sharp & Dohme LLC Recruiting
ClinicalTrials.gov
A Study of SPY072 in Rheumatic Disease
Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Rheumatic Diseases; Rheumatic Joint Disease; PsA (Psoriatic Arthritis); AxSpA; Rheumatologic Disease Interventions: Drug:
ClinicalTrials.gov
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus; Idiopahic Inflammatory Myopathies; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Sjögren’s Syndrome; Antiphospholipid Syndrome; Immune Thrombocytopenia; Systemic Sclerosis Interventions:
ClinicalTrials.gov
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
Conditions: Arthritis, Rheumatoid Interventions: Drug: Tulisokibart; Drug: Placebo; Drug: Methotrexate Sponsors: Merck Sharp & Dohme LLC Recruiting